Cidara Therapeutics : Provides Corporate Update and Reports Third Quarter 2023 Financial Results - Form 8-K -November 02, 2023 at 04:25 pm EDT

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results


SAN DIEGO, November 2, 2023- Cidara Therapeutics, Inc. , a biotechnology company...

Related Keywords

Japan ,San Diego ,California ,United States ,Nicole Davarpanah ,Veronica Eames ,Genentech Roche ,Jeffrey Stein ,Brian Ritchie ,Mundipharma Medical Company ,Cidara Therapeutics Inc ,Securities Exchange ,European Medicines Agency ,Exchange Commission ,Centers For Medicare Medicaid Services ,Nasdaq ,Lifesci Communications ,Melinta Therapeutics ,Janssen Pharmaceuticals Inc ,Translational Research Development ,Committee For Medicinal Products Human Use ,European Commission ,Janssen Pharmaceutical Companies Of Johnson ,Cidara Therapeutics Provides Corporate Update ,Reports Third Quarter ,Medicinal Products ,Human Use ,Proceed Notice ,Senior Vice President ,Translational Research ,Investigational New Drug Application ,Received Positive ,Invasive Candidiasis ,Medicaid Services ,Received Election ,Janssen Pharmaceuticals ,Janssen Pharmaceutical Companies ,Hosted Rd Day ,Global Investment Conference ,Global Investment ,Translational Lead ,Janssen Collaboration ,Seriesx Convertible Preferred Stock ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Quarterly Report ,Consolidated Statements ,Markets ,